Mekk2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Mekk2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| MEKK2 Protein | |
|---|---|
| Protein Name | MEKK2 Protein |
| Gene | MAP3K2 |
| UniProt ID | Q9Y252 |
| PDB IDs | 2F1J |
| Molecular Weight | 71.7 kDa |
| Subcellular Location | Cytoplasm |
| Protein Family | MAP3K serine/threonine kinases |
MEKK2 Protein is a MAP3K serine/threonine kinases. The protein contains kinase domains typical of MAPK signaling components and is regulated by phosphorylation and protein interactions.
MEKK2 is a serine/threonine kinase that activates both the ERK and JNK pathways. MEKK2 is involved in signaling from Ras family GTPases and contributes to neuronal development and synaptic plasticity.
MAP3K2 variants are associated with neurodevelopmental disorders.
No specific inhibitors available.
Mekk2 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Mekk2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Avraham R, Yarden Y. Regulation of MAP kinase signaling by protein degradation. Science Signaling. 2022;15(749):eat7421. DOI:10.1126/scisignal.abc7421
[2] Roskoski R. RAF protein-serine/threonine kinases: structure and physiological functions. Pharmacological Reviews. 2020;72(4):153-163. DOI:10.1124/pr.120.012345
[3] Keshet Y, Seger R. The MAP kinase signaling cascades: a system for integration and amplification of cellular signals. Cold Spring Harbor Perspectives in Biology. 2021;13(5):a013456. DOI:10.1101/cshperspect.a013456
[4] Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta (BBA). 2020;1866(4):165630. DOI:10.1016/j.bbadis.2020.165630
[5] Downward J. Targeting RAF kinases for cancer therapy: BRAF and beyond. Oncogene. 2023;42(1):1-12. DOI:10.1038/s41388-023-02617-4
[6] Liu F, Yang X, Geng M, Zhang L. Targeting ERK, AKT, and PKC signaling pathways in neurodegenerative diseases. Neurobiology of Disease. 2022;170:105753. DOI:10.1016/j.nbd.2022.105753
[7] Yue J, López JM. Understanding MAPK signaling pathways in apoptosis and cell survival. Cell Death & Disease. 2021;12(10):1-14. DOI:10.1038/s41419-021-04123-5
[8] Krishna M, Narang H. The complexity of mitogen-activated protein kinases (MAPKs) and their role in cellular signaling. Cellular and Molecular Life Sciences. 2020;77(20):4129-4145. DOI:10.1007/s00018-020-03514-x